Silverarc Capital Management »

Biohaven shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $260k 10k 26.01
2023-06-30 $478k 20k 23.92

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Biohaven

Stifel Financial
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Perceptive Advisors
Vanguard Group
Redmile Group
Holocene Advisors
Citadel Advisors
Avidity Partners Management
Bellevue Group
Goldman Sachs Group
Oracle Investment Management
A.R. Schmeidler & Co
Charles Schwab Investment Management

View all funds holding Biohaven